10/14/2026
Vir Biotechnology announced a collaboration and license agreement with Gilead Sciences to discover and engineer T-cell engager (TCE) development candidates. ➡️ https://hubs.li/Q04BbHbK0
CONTRACT PHARMA is the only worldwide publication focused on Bio/Pharma contract services, delivering a total qualified circulation of 20,026.
500 N. Franklin Turnpike, Suite 308
Ramsey, NJ
07645
Be the first to know and let us send you an email when Contract Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.